Market Tracker

09/30 6:05pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

During the Trading Day
21.42 -1.64 / -7.11%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
24.05 +2.63 / +12.28%
 
Volume: 49.8K

Today’s Trading

Previous close23.06
Today’s open22.94
Day’s range21.31 - 22.94
Volume397,765
Average volume (3 months)365,159
Market cap$643.6M
Dividend yield--
Data as of 4:00pm ET, 09/30/2014

Growth & Valuation

Earnings growth (last year)-9.82%
Earnings growth (this year)-25.37%
Earnings growth (next 5 years)--
Revenue growth (last year)-35.21%
P/E ratioNM
Price/Sales508.97
Price/Book10.51

Competitors

 Today’s
change
Today’s
% change
RPTPRaptor Pharmaceutica...-0.56-5.52%
RGENRepligen Corp-0.19-0.95%
PRTAProthena Corporation...-0.62-2.72%
INSMInsmed Inc-0.46-3.40%
Data as of 4:00pm ET, 09/30/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$1.1M
Annual profit (last year)-$31.2M
Net profit margin-2,852.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts